Douwe Postmus

3.3k total citations
90 papers, 2.1k citations indexed

About

Douwe Postmus is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Statistics and Probability. According to data from OpenAlex, Douwe Postmus has authored 90 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 23 papers in Cardiology and Cardiovascular Medicine and 20 papers in Statistics and Probability. Recurrent topics in Douwe Postmus's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Heart Failure Treatment and Management (20 papers) and Statistical Methods in Clinical Trials (16 papers). Douwe Postmus is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Heart Failure Treatment and Management (20 papers) and Statistical Methods in Clinical Trials (16 papers). Douwe Postmus collaborates with scholars based in Netherlands, United Kingdom and United States. Douwe Postmus's co-authors include Hans L. Hillege, Tommi Tervonen, Gert van Valkenhoef, Erik Buskens, Adriaan A. Voors, Dirk J. van Veldhuisen, Stephan J. L. Bakker, Nalan Baştürk, Tiny Jaarsma and Marco Metra and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Douwe Postmus

83 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douwe Postmus Netherlands	28	671	397	375	257	243	90	2.1k
Diana Brixner United States	29	450 0.7×	497 1.3×	253 0.7×	329 1.3×	326 1.3×	174	2.7k
Andrea Jorgensen United Kingdom	32	509 0.8×	279 0.7×	109 0.3×	405 1.6×	287 1.2×	107	3.7k
Rae Woong Park South Korea	28	377 0.6×	227 0.6×	331 0.9×	242 0.9×	433 1.8×	191	3.7k
James Lewsey United Kingdom	30	1.0k 1.5×	314 0.8×	531 1.4×	482 1.9×	685 2.8×	68	3.2k
Mary T. Brophy United States	28	986 1.5×	221 0.6×	436 1.2×	478 1.9×	418 1.7×	114	3.3k
Karen Chiswell United States	31	2.1k 3.1×	362 0.9×	548 1.5×	342 1.3×	716 2.9×	183	3.8k
Margaret Piper United States	20	351 0.5×	231 0.6×	430 1.1×	73 0.3×	277 1.1×	52	2.9k
Michael Fralick Canada	30	347 0.5×	194 0.5×	465 1.2×	696 2.7×	397 1.6×	151	2.9k
Gert van Valkenhoef Netherlands	20	366 0.5×	314 0.8×	377 1.0×	120 0.5×	571 2.3×	33	2.6k
Peter R. Rijnbeek Netherlands	31	1.0k 1.6×	233 0.6×	347 0.9×	358 1.4×	375 1.5×	120	4.3k

Countries citing papers authored by Douwe Postmus

Since Specialization

Citations

This map shows the geographic impact of Douwe Postmus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douwe Postmus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douwe Postmus more than expected).

Fields of papers citing papers by Douwe Postmus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douwe Postmus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douwe Postmus. The network helps show where Douwe Postmus may publish in the future.

Co-authorship network of co-authors of Douwe Postmus

This figure shows the co-authorship network connecting the top 25 collaborators of Douwe Postmus. A scholar is included among the top collaborators of Douwe Postmus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douwe Postmus. Douwe Postmus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pignatti, Francesco, Peter G. M. Mol, Chantal Quinten, et al.. (2025). Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions. The Lancet Oncology. 26(6). 664–666.

Heidenreich, Sebastian, Douwe Postmus, & Tommi Tervonen. (2024). Multidimensional Thresholding for Individual-Level Preference Elicitation. Value in Health. 27(6). 737–745. 2 indexed citations

Viddeleer, Alain R., et al.. (2024). CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis. Lung Cancer. 199. 108054–108054. 1 indexed citations

Norden, Yvette van, Jurjen Versluis, Anita W. Rijneveld, et al.. (2024). Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi‐state modeling. Cancer Medicine. 13(9). e6756–e6756. 2 indexed citations

Voors, Adriaan A., Marco Metra, Douwe Postmus, et al.. (2024). End-organ Protective Effect of Serelaxin in Patients Hospitalized for Heart Failure: Results of the Biomarker Substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2). European Journal of Heart Failure. 27(7). 1215–1223. 1 indexed citations

Postmus, Douwe, et al.. (2023). Attitudes of healthcare professionals and drug regulators about progression-free survival as endpoint in the advanced cancer setting. European Journal of Cancer. 197. 113496–113496. 3 indexed citations

Berger, Rolf M.F., Tjark Ebels, Douwe Postmus, et al.. (2023). Cardiac output drop reflects circulatory attrition after Fontan completion: serial cardiac magnetic resonance study. PubMed. 1(2). qyad039–qyad039.

Dijk, Boukje A. C. van, Douwe Postmus, Boudewijn E. C. Plaat, et al.. (2022). Prediction of Poor Outcome for Cutaneous Squamous Cell Carcinoma of the Head and Neck Comparing Classification Systems: A Competing Risk Analysis. Journal of Investigative Dermatology. 142(9). 2532–2534.e4. 3 indexed citations

Vark, Laura C. van, Douwe Postmus, Elisabeth M. W. J. Utens, et al.. (2021). Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study. European Journal of Cardiovascular Nursing. 21(3). 205–212. 17 indexed citations

10.

McMurray, John J.V., David C. Wheeler, Bergur V. Stefánsson, et al.. (2021). Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure. JACC Heart Failure. 9(11). 807–820. 62 indexed citations

11.

Douwes, Johannes M., Willemijn M. H. Zijlstra, Erika B. Rosenzweig, et al.. (2021). Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine. Annals of the American Thoracic Society. 19(2). 227–237. 11 indexed citations

12.

Tervonen, Tommi, Francesco Pignatti, & Douwe Postmus. (2019). From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk Tradeoffs. Medical Decision Making. 39(7). 879–885. 9 indexed citations

13.

Postmus, Douwe, et al.. (2018). The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications. Cost Effectiveness and Resource Allocation. 16(1). 23–23. 6 indexed citations

14.

Demissei, Biniyam G., Douwe Postmus, John G.F. Cleland, et al.. (2017). Plasma Biomarkers to Predict or Rule Out Early Post-Discharge Events after Hospitalization gor Acute Heart Failure. European Journal of Heart Failure. 19(6). 728–738. 27 indexed citations

15.

Feenstra, Talitha, Douwe Postmus, Ben J. Slotman, et al.. (2016). Individual patient information to select patients for different radiation techniques. European Journal of Cancer. 62. 18–27. 14 indexed citations

16.

Postmus, Douwe, et al.. (2016). Eliciting Individual Patient Preferences on The Benefits and Risks of Cancer Treatments: Results From A Survey Conducted in Myeloma Patients. Value in Health. 19(7). A746–A746. 3 indexed citations

17.

Klip, IJsbrand T., Douwe Postmus, Adriaan A. Voors, et al.. (2014). Hemoglobin levels and new-onset heart failure in the community. American Heart Journal. 169(1). 94–101.e2. 19 indexed citations

18.

Boer, Rudolf A. de, Qi Cao, Douwe Postmus, et al.. (2013). The WAP Four-Disulfide Core Domain Protein HE4: A Novel Biomarker for Heart Failure. JACC Heart Failure. 1(2). 164–169. 49 indexed citations

19.

Postmus, Douwe, Dirk J. van Veldhuisen, Tiny Jaarsma, et al.. (2011). The COACH Risk Engine: A Multistate Model for Predicting Survival and Hospitalization in Patients with Heart Failure. European Journal of Heart Failure. 14(2). 168–175. 43 indexed citations

20.

Tervonen, Tommi, Hans L. Hillege, Erik Buskens, & Douwe Postmus. (2010). A state-of-the-art multi-criteria model for drug benefit-risk analysis. University of Groningen research database (University of Groningen / Centre for Information Technology). 10001. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact